NVIDIA Offers Coronavirus Researchers Free Access To GPU Tech
Zacks Investment Research | Mar 27, 2020 08:25AM ET
NVIDIA Corporation (NASDAQ:NVDA) has offered its best technology to researchers, who are working to combat the coronavirus crisis. The company recently announced that coronavirus researchers would get a 90-day free access to its GPU-accelerated genome analysis toolkit — Parabricks.
Researchers and scientists are required to conduct genomic sequencing of the virus as well as infected people to develop drugs or vaccines. However, speed is the essence for analyzing genomic sequences, requiring the need for a high-performance computing platform powered by CPUs and GPUs.
Here, NVIDIA’s Parabricks toolkit would prove a milestone in succeeding research. The genome analysis toolkit has capability of processing whole genome of a person under an hour, which earlier took several days.
NVIDIA acquired Parabricks last December in a major move to enhance its offerings in the healthcare space.
Through giving free access of Parabricks, NVIDIA is generating goodwill. Moreover, the free access is expected to help this Zacks Rank #2 (Buy) company retain its customers in these difficult times. You can see Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.